Close

Sage Therapeutics (SAGE), Biogen (BIIB) Phase 3 for Zuranolone for Major Depressive Disorder Shows Statistically Significant Improvement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. SPOT
4. GM
5. AMZN
6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA


Go back to Sage Therapeutics (SAGE), Biogen (BIIB) Phase 3 for Zuranolone for Major Depressive Disorder Shows Statistically Significant Improvement
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 193.18 -0.93 (0.48%)
Previous Close $194.11    52 Week High $333.65 
Open $193.34    52 Week Low $223.02 
Day High $195.86    P/E 24.73 
Day Low $192.75    EPS $7.81 
Volume 1,458,852       

Sagebrush Gold Ltd. (NASDAQ: SAGE) Delayed: 12.95 +0.06 (0.47%)
Previous Close $12.89    52 Week High $62.64 
Open $12.91    52 Week Low $26.28 
Day High $13.38    P/E N/A 
Day Low $12.74    EPS $-0.94 
Volume 815,165